Pituitary Medicine From Discovery to Patient-Focused Outcomes.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26908107.
- Also identified by DOI 10.1210/jc.2015-3653 and PMC identifier 4803158.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This perspective traces a pipeline of discovery in pituitary medicine over the past 75 years. To place in context past advances and predict future changes in understanding pituitary pathophysiology and clinical care. Author's perspective on reports of pituitary advances in the published literature. Clinical and translational Endocrinology. Discovery of the hypothalamic-pituitary axis and mechanisms for pituitary control, have culminated in exquisite understanding of anterior pituitary cell function and dysfunction. Challenges facing the discipline include fundamental understanding of pituitary adenoma pathogenesis leading to more effective treatments of inexorably growing and debilitating hormone secreting pituitary tumors as well as medical management of non-secreting pituitary adenomas. Newly emerging pituitary syndromes include those associated with immune-targeted cancer therapies and head trauma. Novel diagnostic techniques including imaging genomic, proteomic, and biochemical analyses will yield further knowledge to enable diagnosis of heretofore cryptic syndromes, as well as sub classifications of pituitary syndromes for personalized treatment approaches. Cost effective personalized approaches to precision therapy must demonstrate value, and will be empowered by multidisciplinary approaches to integrating complex subcellular information to identify therapeutic targets for enabling maximal outcomes. These goals will be challenging to attain given the rarity of pituitary disorders and the difficulty in conducting appropriately powered prospective trials.
Medical subject headings
- Pituitary Neoplasms